Androgen, Estrogen and Progestin Binding in Cytosols of Benign Gynecologic Tumors and Tumor-Like Lesions

R. Punnonen; K. Pettersson; R. Vanharanta; A. Lukola

doi:10.1055/s-2007-1013618

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000025.xml

Share / Bookmark

Facebook Linkedin Weibo

Download PDF

Horm Metab Res 1985; 17(11): 607-609
DOI: 10.1055/s-2007-1013618

Clinical

Androgen, Estrogen and Progestin Binding in Cytosols of Benign Gynecologic Tumors and Tumor-Like Lesions

R. Punnonen¹ , K. Pettersson² , R. Vanharanta³ , A. Lukola⁴

¹Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland
²Biochemical Laboratory of Wallac, Åbo Akademi, Turku, Finland
³Department of Pathology, Turku University Central Hospital, Turku, Finland
⁴Department of Biochemistry and Pharmacy, Åbo Akademi, Turku, Finland

Further Information

Publication History

1983

1984

Publication Date:
14 March 2008 (online)

Also available at

PDF Download Permissions and Reprints

Summary

Specific androgen (Kd 0.27±0.06 nM), estrogen (Kd 0.19±0.04 nM) and progestin (Kd 0.22±0.07 nM) binding were investigated in benign gynecologic tumors and tumor-like lesions. The simultaneous presence of androgen and progestin receptors was a common finding. In one endo-metrioma, specific androgen, estrogen and progestin binding was observed simultaneously.

Key-Words:

Androgen - Estrogen and Progestin Receptors - Gynecologic Tumors